"Inflammaging" might sound like a meaningless buzzword. However, this portmanteau of "inflammation" and "aging" is becoming increasingly common in the longevity space, and innovators in the field, including BioLongevity Labs, are developing specialized molecules to combat it.
The term "inflammaging" was coined in 2000, but in recent years, it's seen a resurgence in the field of longevity medicine and popular discourse alike. It refers to low-grade, chronic inflammation that often arises with age, and it's been linked to cancer, Alzheimer's disease, and other age-related conditions.
Healthy lifestyle choices can help keep inflammaging in check, but even the healthiest bodies have trouble controlling inflammation responses as they get older. Like aging itself, inflammaging may seem inevitable.
Health-optimization company BioLongevity Labs has created what it claims is a powerful antidote: a modified version of a protein called Klotho.
Klotho is a protein that occurs naturally in the human body. It's primarily made in the brain and kidneys, and it has powerful anti-aging properties. It's named after one of the three Fates in Greek mythology responsible for spinning the thread of life.
It might also be the next big thing in longevity medicine.
"Klotho is arguably one of the strongest anti-aging molecules known to man," says Jay Campbell, co-founder of BioLongevity Labs. "At BioLongevity Labs, we have created something called α-Klotho LR. This is a patented and modified version of the recombinant Klotho protein that takes α-Klotho and combines it with a proprietary 29-amino acid long albumin-binding construct."
Campbell explains this addition makes the company's Klotho more bioavailable than alternatives.
"The patented albumin binder is our secret sauce, one that has been developed, perfected, and patented over many years by our chemist," he says.
"This albumin binder is what allows us to create a version of Klotho with improved efficacy, better absorption, prevention of metabolic breakdown (i.e., better stability), and an extended half-life to result in a controlled release."
How exactly does Klotho combat inflammaging? One of its most critical functions is boosting the activity of antioxidant enzymes. Oxidative stress is a major driver of age-related decline.
It causes molecular damage to cells and DNA, and over time, that damage can lead to wrinkles, cognitive decline, and even degenerative diseases. Antioxidants keep oxidative stress in check. Because Klotho stimulates antioxidant activity over time, it may help users avoid some of the most serious consequences of inflammaging.
Klotho also fights aging by acting on immune cells. It suppresses inflammatory signaling pathways in the body, making it possible to control inflammatory responses.
As it becomes apparent that many (if not most) forms of age-related decline are tied directly to inflammation, Campbell and others in the field are beginning to think Klotho may one day be a cornerstone of longevity medicine.
"Inflammation control is the next frontier," says Campbell. "Chronic inflammation is the silent killer behind most degenerative diseases."
BioLongevity Labs' improved version of the Klotho protein is showing great promise already. However, it will likely be some time before it's available for therapeutic use. BioLongevity Labs creates compounds made for research use only. Klotho might not be the mythical fountain of youth, but for now, it's the closest thing the field of longevity science has to offer.
© 2026 ScienceTimes.com All rights reserved. Do not reproduce without permission. The window to the world of Science Times.
